RBM15 and Hepatic fibrosis: Although the outcome of RBM15::MRTFA is reportedly similar to that of other patients with childhood AML (3, 8, 10), we noted a poor outcome with early death in five of nine (56%) patients with liver fibrosis (Table 1).